Adagene (ADAG) Payables (2019 - 2025)
Adagene's (ADAG) quarterly Payables came in at $7152.7 billion in Q4 2025, down 21.49% year-on-year from $9110.7 billion in Q4 2024, and up 125011343.47% on a QoQ basis from $5.7 million in Q2 2025.
Adagene (ADAG) Payables (2019 - 2025) Analysis & Trends
Adagene (ADAG) has 7 years of Payables data on file, last reported at $7152.7 billion in Q4 2025.
- On a quarterly basis, Payables fell 21.49% year-over-year to $7152.7 billion in Q4 2025; TTM through Dec 2025 was $7152.7 billion, a 21.49% decrease from a year earlier, with the FY2025 full-year figure at $7152.7 billion, down 21.49% from the prior year.
- Payables for Q4 2025 stood at $7152.7 billion, up from $5.7 million in the prior quarter.
- Over the last five years, Payables for ADAG reached as high as $14434.9 billion in Q4 2022 and fell as low as $5.7 million in Q2 2025.
- Historically, Payables has averaged $6213.3 billion across 5 years, with a median of $7241.0 billion in 2023.
- Across the five-year window, Payables jumped 224044991.29% in 2022 and slumped 100.0% in 2024, its largest moves.
- Year by year, Payables stood at $6.4 million in 2021, then soared by 224044991.29% to $14434.9 billion in 2022, then tumbled by 49.22% to $7329.4 billion in 2023, then advanced by 24.3% to $9110.7 billion in 2024, then dropped by 21.49% to $7152.7 billion in 2025.
- Per Business Quant data, the three most recent Payables figures were $7152.7 billion in Q4 2025, $5.7 million in Q2 2025, and $9110.7 billion in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 5.74 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 10.62 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 423.55 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 694,346.76 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 489.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.03 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.52 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 80.54 Mn |
| 10 | Adagene | 198.85 Mn | 198.85 Mn | - | 7,152.66 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 7,152.66 Bn |
| Jun 30, 2025 | 5.72 Mn |
| Dec 31, 2024 | 9,110.73 Bn |
| Jun 30, 2024 | 7.58 Mn |
| Dec 31, 2023 | 7,329.43 Bn |
| Jun 30, 2023 | 13,479.32 Bn |
| Dec 31, 2022 | 14,434.87 Bn |
| Jun 30, 2022 | 10,625.88 Bn |
| Dec 31, 2021 | 6.44 Mn |
| Jun 30, 2021 | 6.69 Mn |
| Dec 31, 2020 | 5.64 Mn |
| Dec 31, 2019 | 1.43 Mn |